These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27576011)

  • 1. Why Are There So Many Mastectomies in the United States?
    Mamtani A; Morrow M
    Annu Rev Med; 2017 Jan; 68():229-241. PubMed ID: 27576011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy?
    Johns N; Dixon JM
    Eur J Surg Oncol; 2016 Nov; 42(11):1636-1641. PubMed ID: 27665053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision Making in the Surgical Management of Invasive Breast Cancer-Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy.
    Newman LA
    Oncology (Williston Park); 2017 May; 31(5):359-68. PubMed ID: 28512732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
    Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
    Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer treatment in mutation carriers: surgical treatment.
    Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
    Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of breast-conserving therapy vs mastectomy in women under age 40: National trends and potential survival implications.
    Lazow SP; Riba L; Alapati A; James TA
    Breast J; 2019 Jul; 25(4):578-584. PubMed ID: 31090168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
    Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
    Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preferred treatment for young women with breast cancer--mastectomy versus breast conservation.
    van Nes JG; van de Velde CJ
    Breast; 2006 Dec; 15 Suppl 2():S3-10. PubMed ID: 17382859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age, molecular subtypes and local therapy decision-making.
    Kuijer A; King TA
    Breast; 2017 Aug; 34 Suppl 1():S70-S77. PubMed ID: 28666919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral prophylactic mastectomy.
    Benson JR; Winters ZE
    Br J Surg; 2016 Sep; 103(10):1249-50. PubMed ID: 27465285
    [No Abstract]   [Full Text] [Related]  

  • 12. An Analysis of the Decisions Made for Contralateral Prophylactic Mastectomy and Breast Reconstruction.
    Buchanan PJ; Abdulghani M; Waljee JF; Kozlow JH; Sabel MS; Newman LA; Chung KC; Momoh AO
    Plast Reconstr Surg; 2016 Jul; 138(1):29-40. PubMed ID: 27348637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Evaluation of the Choice for Contralateral Prophylactic Mastectomy and Patient Concerns About Recurrence in a Reconstructed Cohort.
    Sando IC; Billig JI; Ambani SW; Kraft CT; Kidwell KM; Zhong L; Chung KC; Momoh AO
    Ann Plast Surg; 2018 Apr; 80(4):333-338. PubMed ID: 29166308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral Mastectomy in Women With Unilateral Breast Cancer: A Review.
    Lim DW; Metcalfe KA; Narod SA
    JAMA Surg; 2021 Jun; 156(6):569-576. PubMed ID: 33566074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.
    McGuire KP; Santillan AA; Kaur P; Meade T; Parbhoo J; Mathias M; Shamehdi C; Davis M; Ramos D; Cox CE
    Ann Surg Oncol; 2009 Oct; 16(10):2682-90. PubMed ID: 19653046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of life in relation to patient education regarding surgical procedures in primary breast carcinoma].
    Gerber B; Krause A
    Zentralbl Gynakol; 1997; 119(4):149-53. PubMed ID: 9206919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When is contralateral mastectomy warranted in unilateral breast cancer?
    Barry M; Sacchini V
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1209-14. PubMed ID: 21916574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Taking control of cancer': understanding women's choice for mastectomy.
    Covelli AM; Baxter NN; Fitch MI; McCready DR; Wright FC
    Ann Surg Oncol; 2015 Feb; 22(2):383-91. PubMed ID: 25190120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between Breast Conservation-Eligible Patients and Unilateral Mastectomy Patients in Choosing Contralateral Prophylactic Mastectomies.
    Sabel MS; Kraft CT; Griffith KA; Bensenhaver JM; Newman LA; Hawley ST; Momoh AO
    Breast J; 2016 Nov; 22(6):607-615. PubMed ID: 27564723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.